One Year Pacing Dependency After TAVR
Launched by UNIVERSITY HOSPITAL, MONTPELLIER · Dec 31, 2024
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying patients who need a permanent pacemaker after a procedure called TAVR (Transcatheter Aortic Valve Replacement) for a heart condition known as aortic stenosis. The trial aims to find out how many of these patients are still dependent on their pacemakers one year after getting them. Researchers want to learn more about the types of heart conduction issues that lead to pacemaker implantation and whether many patients might not need the pacemaker after some time.
To be eligible for this trial, participants must be patients who require a permanent pacemaker after TAVR. However, if someone already had a pacemaker before the TAVR procedure, they cannot join the study. Participants can expect to be monitored for a year to see how often their pacemakers are actually needed and to understand more about their specific heart conditions. This information will help doctors make better decisions about when to recommend pacemaker implantation after TAVR in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • all patients who need a permanent pacemaker implantation after TAVR
- Exclusion Criteria:
- • Patients who have already a pace maker before TAVR
About University Hospital, Montpellier
The University Hospital of Montpellier is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its commitment to patient-centered care, the hospital collaborates with multidisciplinary teams to explore cutting-edge treatments and therapies across various medical fields. By integrating clinical practice with education and research, the University Hospital of Montpellier aims to enhance health outcomes and contribute to the scientific community's understanding of complex medical conditions. Its robust infrastructure and expertise make it a pivotal player in the landscape of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Montpellier, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported